Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Ventricular Repolarization Markers in Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Emre Yılmaz
Ertan Aydın
Sencer Çamcı
Devrim Kurt
Ercan Aydın
机构：
[1] Giresun University Medical Faculty,Department of Cardiology
[2] Kanuni Training and Research Hospital,Department of Cardiology
来源：
Cardiovascular Drugs and Therapy | 2024年 / 38卷
关键词：
Heart failure with reduced ejection fraction; QT dispersion; SGLT-2 inhibitors; Tp-e; Tp-e/QTc; Ventricular repolarization markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：327 / 333
页数：6
相关论文
共 50 条
  • [31] Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
    Bo Liang
    Yi Liang
    Ning Gu
    BMC Cardiovascular Disorders, 22
  • [32] Sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism
    Anker, Stefan D.
    Khan, Muhammad Shahzeb
    Shahid, Izza
    Filippatos, Gerasimos
    Coats, Andrew J. S.
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (08) : 1250 - 1255
  • [33] Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
    Liang, Bo
    Liang, Yi
    Gu, Ning
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [34] Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Fragakis, Nikolaos
    Karagiannis, Asterios
    Doumas, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 179 : 111 - 114
  • [35] Outcomes of sodium-glucose co-transporter type 2 inhibitors use in elderly patients with heart failure with reduced ejection fraction
    Balaguer German, J.
    Cortes Garcia, M.
    Rodriguez Lopez, C.
    Romero Otero, J. M.
    Esteban Chapel, J. A.
    Nieto Roca, L.
    Martinez Milla, J.
    Taibo Urquia, M.
    Pello Lazaro, A. M.
    Tunon Fernandez, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2536 - 2536
  • [36] Totality of evidence in trials of sodium glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice
    Butler, Javed
    Zannad, Faiez
    Filippatos, Gerasimos
    Anker, Stefan D.
    Packer, Milton
    EUROPEAN HEART JOURNAL, 2020, 41 (36) : 3398 - 3401
  • [37] Sodium-glucose co-transporter-2 inhibitors as oral antidiabetic in patients wit heart failure
    Jose Morgado, J.
    Roa Garrido, J. R. G.
    Rodriguez Ortega, P. R. O.
    Martinez Mora, B. M. M.
    Camacho Freire, S. C. F.
    Moraleda Salas, T. M. S.
    Lopez Suarez, A. L. S.
    Diaz Fernandez, J. D. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 452 - 452
  • [38] Sodium-glucose co-transporter-2 inhibitors in the non-diabetic heart failure patient
    Essa, Hani
    Walker, Lauren
    Sankaranarayanan, Rajiv
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2566 - 2570
  • [39] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Khan, Muhammad Shahzeb
    Vaduganathan, Muthiah
    CURRENT DIABETES REPORTS, 2020, 20 (11)
  • [40] What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
    Muhammad Shahzeb Khan
    Muthiah Vaduganathan
    Current Diabetes Reports, 2020, 20
12345